GeneXSTEM™ Stem Cell Injections
Friday, April 17, 2020
Upon evaluation of Umbilical Cord Derived Wharton’s Jelly for Regenerative Medicine Applications, results confirm that there are numerous growth factors, cytokines, hyaluronic acid and extracellular vesicles including exosomes present in the Wharton’s Jelly formulation analyzed. The formulation analyzed is BioIntegrate’s current GeneXSTEM™ product.
Comparison of published literature reveals that the amount of these factors in Wharton’s Jelly are higher compared to other biologics (PRP, amniotic fluid, amniotic membrane, bone marrow tissue, adipose-derived tissue).
We believe the presence of multiple factors within one WJ formulation may play an important role in reducing inflammation, pain and augment healing of musculoskeletal injuries.